Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics

@article{Soshitova2012PredictingPT,
  title={Predicting prothrombotic tendencies in sepsis using spatial clot growth dynamics},
  author={Natalia P. Soshitova and S.S. Karamzin and A. N. Balandina and Olga A. Fadeeva and Anna V. Kretchetova and G M Galstian and Mikhail A. Panteleev and Fazoil I. Ataullakhanov},
  journal={Blood Coagulation \& Fibrinolysis},
  year={2012},
  volume={23},
  pages={498–507}
}
Inflammation in sepsis is associated with hypercoagulation that may lead to thrombosis and disseminated intravascular coagulation. Conventional diagnostic assays are poorly sensitive to procoagulant changes in sepsis. Objectives of the article is to study changes in hemostatic state of septic patients using spatial clot growth assay (currently being developed under the trademark of thrombodynamics) and to compare the sensitivity of this method with the sensitivity of conventional methods… 
Hypercoagulation detected by routine and global laboratory hemostasis assays in patients with infective endocarditis
TLDR
It is suggested that coagulation in patients with infective endocarditis is characterized by general hypercoagulability and platelet pre-activation, which presumably can indicate progressing ofhypercoagulation into consumption coagulopathy.
Preserved clot formation detected by the Thrombodynamics analyzer in patients with cirrhosis.
TLDR
The novel Thrombodynamics assay showed preserved clot formation in plasma from patients with cirrhosis, which is in line with the results of the thrombin generation assay in this study and previously reported by others.
The method of in vivo evaluation of hemostasis: Spatial thrombodynamics
TLDR
Thrombodynamics is a promising method for measuring coagulation by imitation of in vivo conditions, and is being used in basic research and in patients with sepsis.
The clinical utility of fibrin-related biomarkers in sepsis
TLDR
Clinically, all three fibrin-related markers could discriminate between patients with sepsis, SIRS and healthy individuals with FDP, and D-dimer showing statistical significance, and FDP would be preferable for monitoring with its statistically significant time-dependent prediction of survival or death from sepsi.
Global assays of hemostasis in the diagnostics of hypercoagulation and evaluation of thrombosis risk
TLDR
It is concluded that existing global assays have a potential to be an important tool of hypercoagulation diagnostics, but their lack of standardization currently impedes their application.
Fibrinolysis during liver transplantation: analysis by the Thrombodynamics method
TLDR
The Thrombodynamics-4D assay (TD4D) allows the dynamic analysis of fibrin clot formation and lysis but only recognises the most severe forms of hyperfibrinolysis during OLT.
Hyper-coagulability in obese patients accurately identified by combinations of global coagulation assay parameters.
TLDR
Combinations of CAT assay parameters and of parameters of thrombin generation burst with final fibrin clot properties allow recognizing accurately hyper-coagulable plasma and may represent predictive markers for thrombotic events.
Investigation of the phenotype heterogeneity in severe hemophilia A using thromboelastography, thrombin generation, and thrombodynamics.
TLDR
The results suggest that severe and mild HA phenotypes could be distiguished by TG assay in PRP suggesting that difference in platelet activity can be involved in the phenotype formation.
Can We Measure the Individual Prothrombotic or Prohemorrhagic Tendency by Global Coagulation Tests?
TLDR
This review describes the development and application of global coagulation tests, concentrating on the more widely used methods of viscoelastometry and thrombin generation, with a focus on conditions characterized by simultaneous changes of various components of hemostasis, such as anticoagulant therapy or hormone-induced coagulopathy.
Laboratory tests for coagulation system monitoring in a patient with β-thalassemia
TLDR
The potential of the thrombodynamics assay to serve as a sensitive method for coagulation system monitoring and prediction of prothrombotic tendencies in patients with hemolytic anemias is demonstrated.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 39 REFERENCES
Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation
TLDR
It is concluded that thromboelastometry may be a valuable tool in assessing whole blood coagulation capacity in patients with severe sepsis with and without overt DIC.
Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study
TLDR
Key variables of ROTEM® remained within the reference ranges during the phase of critical illness in this cohort of patients with severe sepsis and septic shock without bleeding complications.
Hemophilia A and B are associated with abnormal spatial dynamics of clot growth.
TLDR
The results suggest that clot growth is a process consisting of two distinct phases, initiation and elongation, irrespective of the activation pathway.
Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls
TLDR
Global tests of haemostasis suggest that in this patient group, activation of ha Hemostasis is delayed but once initiated thrombin generation and clot formation are normal or enhanced.
International Society on Thrombosis and Haemostasis score for overt disseminated intravascular coagulation predicts organ dysfunction and fatality in sepsis patients
TLDR
The ISTH DIC score is useful to identify patients with coagulation activation, predicting fatality and disease severity, and mainly depends on the prolongation of the prothrombin time and platelet counts.
Prognostic values of the factor Xa-activated clotting time and endogenous thrombin potential in patients suspected of having disseminated intravascular coagulation.
TLDR
The results suggest that the Xact and ETP may be useful diagnostic and prognostic markers for the DIC, and among various markers, the XACT serves as a good prediction of the 28-day mortality in patients suspected of having DIC.
Dynamic evolution of coagulopathy in the first day of severe sepsis: Relationship with mortality and organ failure*
TLDR
Continuation or worsening of coagulopathy during the first day of severe sepsis was associated with increased development of new organ failure and 28-day mortality, and results further suggest that coagulation abnormalities contribute to organ Failure and death.
Dynamics of clot growth induced by thrombin diffusing into nonstirred citrate human plasma.
TLDR
It was hypothesized that an as yet unknown mechanism is responsible for the inhibition of clot growth and the clot weight observed at the plateau varied only slightly in the range of thrombin concentrations of 50-770 nM.
Analysis of hemostasis alterations in sepsis
TLDR
Endotoxin reactivity, fibrinogen function + antigen + ratio and plasminogen activator inhibitor-1 (citrated plasma), and D-dimer, soluble intercellular adhesion molecule-1, thrombin activity (EDTA–arginine-stabilized plasma) presented large aberrations in septic patients when compared with normal values and may therefore be particularly interesting as markers of hemostasis alteration.
Coagulopathy of sepsis.
TLDR
Based on case reports, treatment with drotrecogin alfa (activated) or substitution of protein C have been recommended for adjuvant treatment of sepsis-related purpura fulminans, including a subgroup of patients fulfilling the laboratory criteria of overt DIC.
...
1
2
3
4
...